Growth Metrics

Mannkind (MNKD) Operating Margin (2010 - 2026)

Mannkind (MNKD) reported Operating Margin of 1.85% for Q1 2026, down 3030.0% year-over-year from 0.06% in Q1 2025, and up 73.08% on a QoQ basis from 6.87% in Q4 2025.

Mannkind (MNKD) has 14 years of Operating Margin data on file, last reported at 1.85% in Q1 2026.

  • Quarterly Operating Margin fell 3030.0% year-over-year to 1.85% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 4.11% (down 2215.0% YoY) and the FY2025 annual result came in at 11.12%, down 1431.0% from the prior year.
  • Operating Margin advanced to 1.85% in Q1 2026 per MNKD's latest filing, from 6.87% in the prior quarter.
  • Across five years, Operating Margin topped out at 34.51% in Q4 2024 and bottomed at 6818.0% in Q2 2022.
  • The 5-year median for Operating Margin is 6.92% (2025), against an average of 405.72%.
  • The widest annual swing landed in 2022, when Operating Margin tumbled 677387 bps; it then soared 682154 bps in 2023.
  • Tracing MNKD's Operating Margin over 5 years: stood at 35.47% in 2022, then soared by 138 bps to 13.44% in 2023, then surged by 157 bps to 34.51% in 2024, then sank by 120 bps to 6.87% in 2025, then jumped by 73 bps to 1.85% in 2026.
  • Per Business Quant, the three latest MNKD Operating Margin figures stand at 1.85% (Q1 2026), 6.87% (Q4 2025), and 23.01% (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Operating Margin (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn -6.43%
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 38.10%
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn 17.83%
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 23.02%
10 Mannkind 1.09 Bn 956.66 Mn 82.66 Mn -1.85%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -1.85%
Dec 31, 2025 -6.87%
Sep 30, 2025 23.01%
Jun 30, 2025 6.92%
Mar 31, 2025 28.45%
Dec 31, 2024 34.51%
Sep 30, 2024 18.21%
Jun 30, 2024 22.95%
Mar 31, 2024 25.24%
Dec 31, 2023 13.44%
Sep 30, 2023 9.94%
Jun 30, 2023 3.54%
Mar 31, 2023 -14.76%
Dec 31, 2022 -35.47%
Sep 30, 2022 -29.28%
Jun 30, 2022 -6,818.00%
Mar 31, 2022 -177.25%
Dec 31, 2021 -191.51%
Sep 30, 2021 -29.67%
Jun 30, 2021 -44.13%
Mar 31, 2021 -35.51%
Dec 31, 2020 -128.76%
Sep 30, 2020 -59.47%
Jun 30, 2020 -3,957.50%
Mar 31, 2020 -43.86%
Dec 31, 2019 -70.98%
Sep 30, 2019 -1,254.14%
Jun 30, 2019 -5,476.00%
Mar 31, 2019 -77.45%
Dec 31, 2018 -48.22%
Sep 30, 2018 -482.05%
Jun 30, 2018 -527.54%
Mar 31, 2018 -773.13%
Dec 31, 2017 -636.58%
Sep 30, 2017 -1,379.30%
Jun 30, 2017 -1,459.59%
Mar 31, 2017 -651.45%
Dec 31, 2016 -95.40%
Sep 30, 2016 72.82%
Sep 30, 2012 -101,391.43%
Mar 31, 2011 -76,002.00%
Jun 30, 2010 -40,067.74%